Telehealth providers in North Dakota
By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed. Last verified
Telehealth prescribing is allowed in North Dakota, including asynchronous care. What North Dakota requires of telehealth prescribers and pharmacies, plus listings with their verification status.
North Dakota at a glance
- Pharmacy regulator
- North Dakota State Board of Pharmacy
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async allowed
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Telehealth providers serving North Dakota
Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.
Telehealth provider · 17 products · partner lists from $172 a month · Says it serves North Dakota (not yet confirmed)
- Prescription only, no research-use-only sales
- Public cancellation and refund policy
We may earn a commission from these links.
Telehealth prescribing rules in North Dakota
NDCC 43-17-44 holds a physician or physician assistant to the same standard of care in telemedicine as in person and requires a bona fide relationship, identity verification, and an examination or evaluation before first diagnosing or treating a patient. The examination may be performed entirely through telemedicine if it is equivalent to an in-person examination. The statute says an examination using secure videoconferencing or store-and-forward technology for appropriate diagnostic testing and use of peripherals that an in-person examination would need meets that standard, while one consisting only of a static online questionnaire or an audio conversation does not. NDCC 43-17-45 then lets a licensee who has performed a qualifying telemedicine examination prescribe according to professional judgment, with opioids restricted. The Board of Medicine's rules in NDAC chapter 50-02-15 repeat the definition of telemedicine, which includes asynchronous store-and-forward technologies. The prescriber must hold a North Dakota license unless a narrow exception applies. None of the peptides in this database are controlled substances. This record classifies asynchronous prescribing as allowed because the statute names store-and-forward technology, alongside secure videoconferencing, as an acceptable way to perform the required examination and then permits prescribing, while barring a static online questionnaire alone. [2] [3]
Compounded GLP-1 access in North Dakota
Because North Dakota requires a full pharmacy permit for every out-of-state shipper, fewer national telehealth pharmacies serve the state, and patients should confirm the pharmacy's North Dakota permit before ordering. [4] [9]
Research use only sellers in North Dakota
The North Dakota Food, Drug, and Cosmetic Act (NDCC chapter 19-02.1) prohibits selling adulterated or misbranded drugs, and NDCC chapter 43-15 limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners. [6] [7] [10]
How to check a telehealth provider in North Dakota
- Confirm the prescriber is licensed or registered to treat patients located in North Dakota; the telehealth rules above explain what North Dakota requires. [2] [3]
- Ask which pharmacy will fill the prescription and check it in the North Dakota State Board of Pharmacy license lookup. [1] [4] [5] [6] [8]
- Get the full price in writing first: consult fees, membership fees, and the medication itself.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in North Dakota. [6] [7] [10]
Common questions in North Dakota
Can an out-of-state pharmacy ship compounded peptides to me in North Dakota?
Only if it holds a North Dakota pharmacy permit issued by the State Board of Pharmacy. North Dakota requires every pharmacy that ships prescription drugs into the state to hold a permit and follow North Dakota rules for that dispensing. [1] [4]
Sources
- [1]North Dakota State Board of Pharmacy
- [2]NDCC 43-17-44, Standard of care and professional ethics, and 43-17-45 (in chapter 43-17, Physicians and physician assistants)
- [3]NDAC chapter 50-02-15, Telemedicine (North Dakota Board of Medicine)
- [4]NDAC chapter 61-08-01, Requirements for out-of-state pharmacies
- [5]NDAC chapter 61-02-01, Pharmacy permits (section 61-02-01-03, pharmaceutical compounding standards)
- [6]NDCC chapter 43-15, Pharmacy (including 43-15-35, pharmacist ownership)
- [7]NDCC chapter 19-02.1, Food, Drug, and Cosmetic Act
- [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [10]21 U.S.C. 331, Prohibited acts